Micha T. Maeder, MD, PhD, Niklas F. Ehl, MD

Slides:

Advertisements

Similar presentations

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,

Advertisements

Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery Emmanuelle.

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC

Relation between Cardiovascular Disease Risk Markers and Brain Infarcts Detected by Magnetic Resonance Imaging in an Elderly Population Ruta Nylander,

Volume 96, Issue 6, Pages (December 1989)

Eulo Lupi-Herrera, M.D., David Bialostozky, M.D., Angel Sobrino, M.D.

Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm? Gerard O. Oghlakian, MD, Ilke Sipahi, MD, James.

Céline Pynnaert, Michel Lamotte, Robert Naeije Respiratory Medicine

582 Change in myocardial oxygenation during mild hypo- and hypercapnia: A blood oxygen level dependent cardiovascular magnetic resonance (BOLD-CMR) study.

Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation Lena Rivard, MD, MSc, Paul Khairy, MD,

Meghan E. Sise, Andrew M. Courtwright, Richard N. Channick

An unusual case of severe aortic valve stenosis in an adult caused by aortic valve inflammatory myofibroblastic tumor Dong Zhao, MD, Chunsheng Wang,

by Victor R. Gordeuk, Oswaldo L. Castro, and Roberto F. Machado

Relationship between perioperative N-terminal pro-brain natriuretic peptide and maximum inotropic score in children after cardiac surgery Yanqin Cui,

Physiological changes in pulmonary arterial hypertension (PAH) patients which occur in response to pregnancy. Physiological changes in pulmonary arterial.

Volume 54, Pages S86-S91 (December 1998)

Cardiovascular Demands of Deer Retrieval Methods

A Cardiac Myxoma With Intense Metabolic Activity

Has the 6-Min Walk Distance Run Its Course?

Cardiac pheochromocytoma

Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery Emmanuelle.

Health Care Use and Associated Time and Out of Pocket Expenditures for Patients With Cardiovascular Disease in a Publicly Funded Health Care System Saba.

Volume 126, Issue 1, Pages 14S-34S (July 2004)

Are preoperative B-type natriuretic peptide levels associated with outcome after pulmonary artery banding and the double switch operation in patients.

Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery Olaf Schouten, MD, Sanne.

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Spontaneous Coronary Artery Dissection and Fibromuscular Dysplasia

Volume 8, Issue 2, Pages (February 2011)

Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018 Marius M. Hoeper, Christian Apitz,

Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm? Gerard O. Oghlakian, MD, Ilke Sipahi, MD, James.

REVEAL pulmonary arterial hypertension (PAH) risk score.

Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery S. Farzi,

Cox proportional hazard estimates for multivariate model of survival, limited to terms included in the final stepwise model. Cox proportional hazard estimates.

Amy C. Arnold, PhD, MSCI, Satish R. Raj, MD, MSCI

Evaluation of right ventricular function after cardiac surgery: The importance of tricuspid annular plane systolic excursion and right ventricular ejection.

Inclusion characteristics of a) previously diagnosed and b) newly diagnosed pulmonary arterial hypertension (PAH) patients enrolled in REVEAL. PVR: pulmonary.

An algorithm for the early diagnosis of pulmonary arterial hypertension in systemic sclerosis. An algorithm for the early diagnosis of pulmonary arterial.

Myriad manifestations of myxoma

Right ventricular outflow tract resection for treatment of refractory ventricular tachycardia in a 2-year-old child S. Kanaan, MD, K. Shamsuddin, MD,

Darren H. Freed, MD, PhD, FRCSC, Bruce M

Michael G. Katz, MD, PhD, Anthony S

An expert proposal for a treat-to-target checklist for pulmonary arterial hypertension (PAH). An expert proposal for a treat-to-target checklist for pulmonary.

Volume 71, Issue 6, Pages (March 2007)

A. Mekontso-Dessap, L. Tual, M. Kirsch, G. D'Honneur, D. Loisance, L

Risk assessment and treat-to-target approach for pulmonary arterial hypertension. Risk assessment and treat-to-target approach for pulmonary arterial hypertension.

Triage in Cardiovascular Emergency Services: Validity and Usefulness of Emergency Severity Index 4 Juan P. Costabel, MD, Luciano Battioni, MD, Noemí.

Leora B. Balsam, MD, Abe DeAnda, MD

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Catheter Ablation for Atrial Fibrillation/Atrial Flutter Atul Verma, MD, FRCPC,

Richard Severin, PT, DPT, CCS, Shane A. Phillips, PT, PhD, FAHA

Tae-Jin Yun, MD, PhD, Seung-Hyun Lee, MD, Jae-Kon Ko, MD, PhD

Misconceptions and Facts about Pericardial Effusion and Tamponade

Michael H. Chiu, MD, Msc, Nakul C. Sharma, MD, MPH CJC Open

Abnormal right atrial and right ventricular diastolic function relate to impaired clinical condition in patients operated for tetralogy of Fallot Saskia.

The role of a defined protocol for cardiac risk assessment in decreasing perioperative myocardial infarction in vascular surgery T.J. Bunt, MD Journal.

Decreased oxygen consumption as a toxic manifestation of protamine sulfate reversal of heparin anticoagulation Thomas W. Wakefield, MD, Ignacio Ucros,

“WHY WARM UP?”: EXERCISE ONSET AND THE EARLY PEAK IN PULMONARY ARTERY WEDGE PRESSURE IN HEALTHY OLDER ADULTS T. Petropoulos, S. Wright, S. Esfandiari,

Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: A safe and effective therapy? Christian Kuntzen, Veit Gülberg, Alexander.

Historical Milestones and Progress in the Research on Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Josef Veselka, MD, PhD Canadian.

Subodh Verma, MD, PhD, Milan Gupta, MD, Paul M. Ridker, MD

High-Risk Mitral Valve Surgery: Perioperative Hemodynamic Optimization with Nesiritide (BNP) Sacha P. Salzberg, MD, Farzan Filsoufi, MD, Anelechi Anyanwu,

Results of classification and regression tree analysis in patients with pulmonary hypertension-sickle cell disease. Results of classification and regression.

Kaplan–Meier survival curves for baseline cardiac magnetic resonance imaging variables according to the median value in patients with pulmonary hypertension.

135 The Association Between Patterns of Myocardial Involvement and Clinical Presentation in Patients With Cardiac Sarcoidosis As Assessed By FDG-PET

Mobile Medicine: Digital Dynamo or Virtual Vaporware

Lipomatous septal hypertrophy

Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events? D. George Wyse,

Right ventricular–pulmonary arterial coupling in patients after repair of tetralogy of Fallot Heiner Latus, MD, Wolfhard Binder, MD, Gunter Kerst, MD,

Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device.

Spontaneous Coronary Artery Dissection

Presentation transcript:

When the Right Is Not Doing Right: The Role of Strain Imaging in Pulmonary Arterial Hypertension Micha T. Maeder, MD, PhD, Niklas F. Ehl, MD Canadian Journal of Cardiology Volume 34, Issue 8, Pages 962-964 (August 2018) DOI: 10.1016/j.cjca.2018.05.009 Copyright © 2018 Canadian Cardiovascular Society Terms and Conditions

Figure 1 Parameters for the diagnosis (left) and risk assessment (prognosis; right) in pulmonary arterial hypertension. Blue: diagnosis according to European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines3; red: included in risk model of the ESC/ERS guidelines3; violet: not included in risk model of ESC/ERS guidelines.3 BNP, B-type natriuretic peptide; CI, cardiac index; mPAP, mean pulmonary artery pressure; mPAWP, mean pulmonary artery wedge pressure; 6 MWD, 6-minute walking distance; NT-proBNP, N-terminal-proBNP; PVR, pulmonary vascular resistance; PE, pericardial effusion; peak VO2, peak oxygen consumption; RA, right atrium; RAP, right atrial pressure; RV, right ventricle; SVI, stroke volume index; VE/VCO2 slope, slope of the minute ventilation to CO2 production relationship. Canadian Journal of Cardiology 2018 34, 962-964DOI: (10.1016/j.cjca.2018.05.009) Copyright © 2018 Canadian Cardiovascular Society Terms and Conditions